Ratings
0
Nobody has rated this yet. Be the first!
Works
23
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization
CD40 activation as potential tool in malignant neoplasms.
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
Evidence of publication bias in clinical trials of biotherapies for solid tumors
Prognostic value of serum VEGF in melanoma patients: a pilot study
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
